Importance: Serotonin reuptake inhibitors (SRIs) are the only medications approved for obsessive-compulsive disorder (OCD), yet most patients taking SRIs exhibit significant symptoms. Adding exposure/response prevention (EX/RP) therapy improves symptoms, but it is unknown whether patients maintain wellness after discontinuing SRIs.
Objective: To assess whether patients with OCD who are taking SRIs and have attained wellness after EX/RP augmentation can discontinue their SRI with noninferior outcomes compared with those who continue their SRI therapy.
Practice guidelines for adults with obsessive-compulsive disorder (OCD) recommend augmenting serotonin reuptake inhibitors (SRIs) with exposure and ritual prevention (EX/RP). However, fewer than half of patients remit after a standard 17-session EX/RP course. We studied whether extending the course increased overall remission rates and which patient factors predicted remission.
View Article and Find Full Text PDFBull Menninger Clin
July 2019
Examination of habituation to disgust-related stimuli has received limited experimental investigation. In this study, 38 undergraduates were divided into two groups. The vomit-blood (VB) group was first exposed to a realistic approximation of vomit and allowed to habituate to this stimulus, while the blood-vomit (BV) group was first allowed to habituate to a realistic approximation of blood.
View Article and Find Full Text PDFBehav Res Ther
February 2004
Much of the existing literature examining the role of disgust is limited to specific phobia. Recent research has begun to examine the role of disgust in contamination fear, a subtype of obsessive-compulsive symptoms. Through the use of behavioral avoidance tasks (BATs), the current study was designed to examine the role of disgust in people with contamination fears, with attention to distinguishing high and low trait anxiety.
View Article and Find Full Text PDF